Analysis Natrium Iodide Symporter Expression in Breast Cancer Subtypes for Radioiodine Therapy Response.
Aisyah ElliyantiDewi RusnitaNita AfrianiYayi Dwina Billianti SusantoVeronica Y SusiloSri SetiyowatiWirsma Arif HarahapPublished in: Nuclear medicine and molecular imaging (2020)
NIS protein expression is detectable in breast cancer cells to varying degrees. HER2+ is the most likely to express NIS in the cell membrane followed by TN subtypes. This indicates that radioiodine could be used as a novel adjuvant treatment in breast cancer.